The data displays the best performing IPOs of 2017 in the U.S., by rate of return since the company IPO until the end of 2017. The stock price of AnaptysBio, a company operating in the health care sector, sold publicly for the first time on Jan 25 2017, increased by 571.5% until the end of 2017.
AnaptysBio (25 Jan) | 571.5 |
Argenx (17 May) | 271.4 |
Roku (27 Sep) | 269.9 |
SMART Global Holdings (23 May) | 206.4 |
UroGen Pharma (3 May) | 186.2 |
Calyxt (19 Jul) | 175.4 |
Appian (24 May) | 162.3 |
Canada Goose Holdings (15 Mar) | 149.9 |
Boston Omaha Corp (15 Jun) | 149.2 |
Floor & Decor Holdings (26 Apr) | 131.8 |